The company grew in the low single digits in 2022 as international growth in its orthopedics line offset competitive pressures in spine.

The company captured market share in 2022, growing more than 24% through new product introductions and expanded distribution.

Shoulder Innovations has developed and commercialized various components for the InSet Glenoid, Humeral Short Stem, Reverse and Stemless implants.

The company declined in the mid-teens during 2022 as it exits markets, fills portfolio gaps and modernizes its operations.

The company grew 23% in 2022, its first year as a publicly traded company. New products and sales force expansion drove the growth.

The company grew more than 44% in 2022 through its sole focus on spine surgery. ATEC expects to grow another 25% in 2023.

The company’s product revenue declined in the low single digits in 2022 as it transforms its business model and contends with supply issues.

The company grew 18% in 2022, driven by accelerating demand momentum in its core SI-fusion business and increased surgeon engagement.

Our chart of the month shows the projected top 10 largest players in spine after recent M&A deals in the market segment.

The company’s MACI sales grew more than 18% for FY22 and greatly accelerated its path toward a new arthroscopic delivery method.